Cargando…
The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
(1) Background: The use of virtual reality (VR) in improving patient comfort related to medical procedures in oncology patients raised the question of whether similar benefits could be obtained by patients with inflammatory bowel disease (IBD). (2) Methods: In this prospective, randomized, controlle...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235083/ https://www.ncbi.nlm.nih.gov/pubmed/34205323 http://dx.doi.org/10.3390/jcm10122709 |
_version_ | 1783714233749340160 |
---|---|
author | Lewandowski, Konrad Kaniewska, Magdalena Rosołowski, Mariusz Kucha, Piotr Rydzewska, Grażyna |
author_facet | Lewandowski, Konrad Kaniewska, Magdalena Rosołowski, Mariusz Kucha, Piotr Rydzewska, Grażyna |
author_sort | Lewandowski, Konrad |
collection | PubMed |
description | (1) Background: The use of virtual reality (VR) in improving patient comfort related to medical procedures in oncology patients raised the question of whether similar benefits could be obtained by patients with inflammatory bowel disease (IBD). (2) Methods: In this prospective, randomized, controlled, single-center clinical trial, a total of 90 patients with IBD treated with vedolizumab were enrolled and randomized in a 1:1 allocation to either the VR immersion group or the routine-treated group. The primary outcome was to evaluate whether VR could decrease stress and anxiety related to a medical procedure. The secondary outcome was to assess the safety of the VR. (3) Results: A statistically significant improvement in well-being and psychological comfort (p = 0.046), feeling of relaxation (p = 0.046), sense of influence on the treatment process (p < 0.001), improved perception of the way the drug works (p < 0.001), improved positive attitude while waiting for the next administration of the drug (p = 0.026), and increased motivation for treatment (p = 0.026) was noticed in the intervention group. There were no statistically significant differences in the incidence of complications in the intervention and control groups. (4) Conclusions: The use of VR had a positive effect on the reduction of stress associated with vedolizumab treatment and could improve compliance. |
format | Online Article Text |
id | pubmed-8235083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82350832021-06-27 The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab Lewandowski, Konrad Kaniewska, Magdalena Rosołowski, Mariusz Kucha, Piotr Rydzewska, Grażyna J Clin Med Article (1) Background: The use of virtual reality (VR) in improving patient comfort related to medical procedures in oncology patients raised the question of whether similar benefits could be obtained by patients with inflammatory bowel disease (IBD). (2) Methods: In this prospective, randomized, controlled, single-center clinical trial, a total of 90 patients with IBD treated with vedolizumab were enrolled and randomized in a 1:1 allocation to either the VR immersion group or the routine-treated group. The primary outcome was to evaluate whether VR could decrease stress and anxiety related to a medical procedure. The secondary outcome was to assess the safety of the VR. (3) Results: A statistically significant improvement in well-being and psychological comfort (p = 0.046), feeling of relaxation (p = 0.046), sense of influence on the treatment process (p < 0.001), improved perception of the way the drug works (p < 0.001), improved positive attitude while waiting for the next administration of the drug (p = 0.026), and increased motivation for treatment (p = 0.026) was noticed in the intervention group. There were no statistically significant differences in the incidence of complications in the intervention and control groups. (4) Conclusions: The use of VR had a positive effect on the reduction of stress associated with vedolizumab treatment and could improve compliance. MDPI 2021-06-19 /pmc/articles/PMC8235083/ /pubmed/34205323 http://dx.doi.org/10.3390/jcm10122709 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lewandowski, Konrad Kaniewska, Magdalena Rosołowski, Mariusz Kucha, Piotr Rydzewska, Grażyna The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab |
title | The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab |
title_full | The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab |
title_fullStr | The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab |
title_full_unstemmed | The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab |
title_short | The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab |
title_sort | use of virtual reality to reduce stress among inflammatory bowel disease patients treated with vedolizumab |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235083/ https://www.ncbi.nlm.nih.gov/pubmed/34205323 http://dx.doi.org/10.3390/jcm10122709 |
work_keys_str_mv | AT lewandowskikonrad theuseofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab AT kaniewskamagdalena theuseofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab AT rosołowskimariusz theuseofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab AT kuchapiotr theuseofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab AT rydzewskagrazyna theuseofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab AT lewandowskikonrad useofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab AT kaniewskamagdalena useofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab AT rosołowskimariusz useofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab AT kuchapiotr useofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab AT rydzewskagrazyna useofvirtualrealitytoreducestressamonginflammatoryboweldiseasepatientstreatedwithvedolizumab |